Abridge Expands Context-Aware Clinical Intelligence Across Partner Health Systems
Abridge is expanding access to its clinical intelligence capabilities, giving partner health systems the ability to make its clinical intelligence agent available to clinicians across their organizations, regardless of how those clinicians currently document patient visits. The expansion represents another step in Abridge’s broader effort to integrate artificial intelligence into everyday clinical workflows and provide clinicians with patient-specific information at the point of care.
Under the expanded model, health systems can make Abridge’s clinical intelligence agent available through the electronic health record (EHR) workflow that clinicians already use or provide access through a dedicated mobile and web experience. Both options are connected to the patient’s medical record, allowing organizations to make the technology available through an enterprise-level decision rather than requiring individual clinicians to adopt the solution separately.
The approach is designed to reduce barriers to AI adoption while maintaining the security, governance and integration standards established by participating health systems. Rather than introducing another standalone application that clinicians have to search for or open separately, Abridge aims to place clinical intelligence directly within existing workflows.
Expanding AI Support Across the Care Team
The development reflects a broader shift in healthcare toward making AI tools available at the point where clinical decisions are made. While many healthcare AI solutions initially spread through individual clinician adoption, health systems increasingly are looking for technologies that can be governed, integrated and deployed across entire organizations.
Abridge’s latest expansion is designed to support that enterprise approach.
Dr. Shiv Rao, CEO and Co-Founder of Abridge and a practicing cardiologist, said the company’s decision-support capabilities have experienced rapid adoption because clinicians view them as a natural extension of the Abridge experience.
The company’s technology is designed to understand the clinical context surrounding the patient, use evidence that clinicians already trust and connect information to the next action a clinician may need to take.
According to Abridge, more than 300 enterprise health systems have adopted its decision-support capabilities since their launch in April. Monthly active users have grown to more than half of eligible Abridge clinicians, while queries per clinician have tripled over the past two months.
These figures suggest that clinical AI is increasingly becoming part of routine healthcare workflows rather than being treated solely as an experimental or supplementary technology.
Enterprise-Wide Deployment Model
One of the key elements of Abridge’s latest offering is its enterprise-wide deployment model.
Instead of requiring every clinician to independently select, install and learn a separate AI application, health systems can extend access through their existing relationship with Abridge. The organization can make the decision to provide the clinical intelligence agent across its care teams while maintaining the same security and governance framework used for its existing Abridge deployment.
This model could be particularly important for large healthcare organizations with thousands of clinicians working across multiple specialties and locations.
For health systems, introducing a new AI solution can involve extensive reviews covering cybersecurity, privacy, data governance, EHR integration and clinical safety. Abridge’s approach is intended to reduce duplication by building the clinical intelligence agent on infrastructure that participating organizations have already reviewed and deployed.
The company says the agent can be securely connected to the longitudinal patient record because access is provisioned by the health system rather than being individually claimed by clinicians.
This means the organization can maintain greater control over how the technology is deployed while clinicians receive access to patient-specific information within approved workflows.
UPMC Highlights Embedded Adoption
UPMC is among the health systems using Abridge’s enterprise-wide approach.
Dr. Rob Bart, CMIO of UPMC Health Services Division, said that the organization’s deployment gives every clinician access to Abridge’s clinical intelligence agent. He also highlighted the level of adoption achieved through clinician self-discovery.
According to UPMC, more than 60% of its Abridge users have adopted the clinical intelligence capabilities largely without additional training campaigns.
That experience highlights an important factor in healthcare technology adoption: workflow integration.
When clinicians must leave their EHR, open another application, enter patient information and search for an answer, even a potentially useful AI tool can create additional friction. When the technology is integrated into the environment where clinicians already work, the number of steps required to use it can be significantly reduced.
UPMC’s experience suggests that intuitive integration may encourage clinicians to explore clinical intelligence capabilities without requiring extensive promotional campaigns or mandatory training.
Supporting Clinical Decisions at the Point of Care
Abridge’s clinical intelligence agent is designed to provide information based on the individual patient rather than relying solely on generic medical questions.
This distinction is important in clinical settings because the relevance of medical information often depends on a patient’s history, medications, diagnoses, laboratory results, symptoms and other factors contained within the medical record.
Dr. Eric Poon, Chief Health Information Officer at Duke Health, said Abridge’s clinical decision-support capabilities can surface information at the moment clinicians need it while taking into account the patient’s specific circumstances.
Duke Health has seen the technology applied to complex cases, including unusual neurological presentations and uncommon facial rashes. By recognizing the broader clinical context, the system can surface relevant guidance and support clinicians as they determine potential next steps.
The goal is not to replace the clinician’s judgment. Instead, the technology is intended to provide relevant information within the workflow so that clinicians can make decisions without interrupting their interaction with patients.
Supporting Clinicians Before, During and After Care
Abridge’s expanded clinical intelligence experience is designed to assist clinicians across multiple stages of the care process.
Before a visit, the platform can provide pre-visit summaries that give clinicians a concise overview of the patient’s history and highlight changes since the previous encounter. By presenting this information before the consultation begins, the technology can help clinicians prepare for the interaction more efficiently.
The platform also includes medical calculators that can be pre-populated with information from the EHR. This can eliminate the need to manually transfer patient information between systems or applications.
During care, clinicians can access medical literature and evidence-based guidance relevant to the patient. Abridge says its clinical intelligence capabilities can draw on validated medical sources, including publications and organizations such as The New England Journal of Medicine, JAMA Network, the American Diabetes Association, the American Academy of Family Physicians, Neurology and the Journal of Clinical Oncology.
For organizations that already use UpToDate, Abridge can also leverage that knowledge repository.
The system can use information from the patient’s chart to shape responses, helping clinicians focus on information most relevant to the individual case.
Clinicians can also query the patient record directly through the same conversational interface, including outside an active encounter.
After care, the technology can assist with administrative and clinical communication tasks. It can generate contextualized clinical artifacts such as referral letters and clinician-to-clinician handoffs using information from the patient’s medical record.
Together, these capabilities are intended to create a continuous clinical intelligence experience rather than a tool designed for only one stage of a patient encounter.
Supporting Specialty Care
Abridge’s enterprise strategy also extends to specialties where clinicians may have additional concerns about AI adoption.
Dr. Amanda Bohleber, Chief Health Informatics Officer at Deaconess Health System, highlighted behavioral health as an example. Behavioral health clinicians often work with highly sensitive patient information, which can make organizations and clinicians particularly cautious about introducing AI technologies.
According to Bohleber, clinicians became more comfortable engaging with the technology when evidence and patient information were already available within the approved clinical environment.
This illustrates the importance of trust in healthcare AI. Clinicians need to understand not only what an AI system can do but also how patient information is handled, where responses come from and how the technology fits into established clinical governance.
By embedding its clinical intelligence capabilities within an existing health-system relationship, Abridge is seeking to address some of those concerns.
Expanding Access Beyond Ambient Documentation Users
Another important aspect of the announcement is that clinicians do not necessarily need to use Abridge’s ambient documentation capabilities to access the clinical intelligence agent.
For clinicians already using Abridge for documentation, the clinical intelligence experience can become part of the existing workflow.
For clinicians who have not adopted ambient documentation, health systems can provide access through Abridge’s mobile and web experience.
This distinction potentially expands the addressable user base within each health system.
Instead of limiting clinical intelligence to clinicians who already use ambient documentation, organizations can extend the capability to broader clinical teams. That could include physicians and other clinicians who have different documentation workflows or who have not yet adopted ambient AI.
Matt Kull, Executive Vice President and Chief Information and Digital Officer at Inova Health System, described the organization’s relationship with Abridge as a broader platform decision rather than simply a documentation purchase.
The ability to extend clinical intelligence across the organization using infrastructure that has already been evaluated and deployed could make it easier for health systems to expand AI adoption.
Connecting Evidence With Patient Context
A central theme of Abridge’s strategy is combining medical evidence with patient-specific information.
Traditional clinical decision-support systems can provide access to medical guidelines, research and reference materials, but clinicians may still have to determine which information applies to the patient in front of them.
Abridge’s approach is intended to bring those two elements together.
The platform can use information from the patient’s chart to contextualize evidence and present information that is relevant to the clinical situation. This can help clinicians move from a broad medical question toward a more specific understanding of how available evidence relates to the patient.
The company also says its technology can suggest additional questions clinicians may want to consider. Such capabilities could help clinicians explore complex cases more systematically while retaining the clinician as the decision-maker.
Building an AI-Native Clinician Intelligence Platform
The latest announcement follows Abridge’s broader expansion beyond ambient clinical documentation.
At its June keynote, the company introduced what it described as an AI-native clinician intelligence platform designed to help health systems coordinate clinical, financial and evidence-based decisions throughout the care journey.
The company has also recently introduced Care Signals, an agentic experience intended to capture the complexity of patient visits.
These developments indicate that Abridge is positioning itself as more than a documentation technology provider. The company is attempting to build a broader AI infrastructure for clinicians that can support multiple stages of healthcare delivery.
The expansion of clinical intelligence across partner health systems is another part of this strategy.
Supporting Clinician Education and Professional Development
The platform also includes an educational component by allowing clinicians to claim AMA PRA Category 1 Credit™ for eligible clinical lines of inquiry they are already pursuing for patients.
This connects clinical decision support with ongoing professional development.
Rather than requiring clinicians to complete separate educational activities unrelated to their daily practice, the approach is designed to connect learning with questions that arise during actual patient care.
Such capabilities could become increasingly relevant as healthcare organizations look for ways to support continuous learning while minimizing additional administrative burdens on clinicians.
Positive Feedback From Health System Leaders
Health system leaders participating in Abridge’s deployments have highlighted the importance of making clinical intelligence available within established workflows.
At Yale New Haven Health, Dr. Lee Schwamm, Senior Vice President and Chief Digital Health Officer, said integrating decision support into the EHR workflow can help clinicians access AI-enabled guidance without disrupting patient interactions.
CHRISTUS Health has similarly highlighted the availability of relevant prompts directly within the clinical workflow.
Dr. Tim Barker, System Medical Director and CMIO of Ambulatory Care at CHRISTUS Health, described the experience as something clinicians can access when needed without the technology becoming disruptive.
UNC Health’s Dr. David McSwain, Chief Medical Informatics Officer, also emphasized the importance of intuitive design. He said Abridge’s new capabilities fit naturally into clinical workflows and reflect the company’s clinician-led approach.
These perspectives point to a common requirement for successful healthcare AI adoption: technology must work within clinical practice rather than forcing clinicians to significantly change how they work.
Abridge’s latest expansion represents a broader effort to make AI-powered clinical intelligence a standard component of healthcare delivery. By enabling partner health systems to extend access across their organizations, the company is moving toward an enterprise model in which clinical AI can be available to entire care teams rather than only to individual early adopters.
The strategy combines several elements: EHR integration, patient-specific context, evidence-based guidance, clinical workflow support and enterprise-level governance.
As health systems continue evaluating AI technologies, these factors are likely to become increasingly important. Healthcare organizations need tools that can provide meaningful clinical value while meeting expectations around security, privacy, governance and usability.
Abridge’s expanding platform is designed to address these requirements through an integrated approach.
The company’s reported growth in clinical intelligence usage also suggests that clinicians are increasingly engaging with AI-based decision support when it is presented in a familiar and context-aware environment. With monthly active users exceeding half of eligible clinicians and queries per clinician increasing substantially in recent months, the company is seeing growing interaction with its decision-support capabilities.
The next phase of Abridge’s development will likely focus on expanding these capabilities across more clinicians and health systems while continuing to improve the depth and relevance of its clinical intelligence.
By making the technology available through existing EHR workflows as well as mobile and web experiences, Abridge is seeking to remove one of the biggest barriers to healthcare AI adoption: friction.
Its broader vision is to create a connected clinical intelligence platform that supports clinicians before, during and after patient encounters, provides evidence in context and helps healthcare organizations make AI available at enterprise scale.
For participating health systems, the expansion could provide a pathway toward broader AI adoption without requiring every clinical department to independently identify, evaluate and implement a new decision-support solution. For clinicians, the objective is simpler: provide useful, patient-specific intelligence at the moment it can have the greatest impact, while allowing the clinician to remain firmly in control of the care decision.
As healthcare continues to integrate artificial intelligence into everyday practice, Abridge’s latest move reflects the industry’s broader transition from isolated AI applications toward integrated, enterprise-wide clinical intelligence.
Source link: https://www.businesswire.com/
